By Colin KellaherBaxter International Inc. on Thursday said it plans to invest roughly $100 million to expand its sterile fill/finish manufacturing plant in Halle/Westfalen, Germany. The Deerfield, Ill., medical-technology company said it will add a syringe filling line, along with additional liquid and freeze-dried vial capacity, at the plant, which is part of BioPharma Solutions, a Baxter unit that engages in the development and contract manufacturing of drug product for injectable pharmaceuticals. Baxter said it expects construction on the new manufacturing building to begin next year, with completion slated for 2024. Write to Colin Kellaher at colin.kellaher@wsj.com

Source: Wall Street Journal November 11, 2021 18:45 UTC